We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW DELHI, INDIA -- (Marketwire) -- 06/02/09 -- W.S.S. is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has determined to wind down its business operations and carry out an orderly disposition of its assets...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has terminated the employment of substantially all of its operational and staff employees at its...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has received a complete response letter from the U.S. Food and Drug Administration pertaining to the...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today financial results for the third fiscal quarter ended February 28, 2009. For the third fiscal quarter, Northfield...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has completed the previously announced sale of shares of convertible preferred stock pursuant to a registered...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has obtained a commitment to purchase shares of convertible preferred stock pursuant to a registered direct...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that it has implemented a number of measures to reduce its cash burn in order to preserve cash for ongoing...
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that researchers from the University of Colorado at Denver / Denver Health Medical Center, Bonfils Blood Center in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions